163 related articles for article (PubMed ID: 37792463)
1. Bridging the Binding Sites 2.0: Photoswitchable Dualsteric Ligands for the Cannabinoid 2 Receptor.
Steinmüller SAM; Tutov A; Hislop JN; Decker M
ACS Chem Neurosci; 2023 Oct; 14(20):3737-3744. PubMed ID: 37792463
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands.
Gado F; Ferrisi R; Polini B; Mohamed KA; Ricardi C; Lucarini E; Carpi S; Domenichini F; Stevenson LA; Rapposelli S; Saccomanni G; Nieri P; Ortore G; Pertwee RG; Ghelardini C; Di Cesare Mannelli L; Chiellini G; Laprairie RB; Manera C
J Med Chem; 2022 Jul; 65(14):9918-9938. PubMed ID: 35849804
[TBL] [Abstract][Full Text] [Related]
3. New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2.
Ferrisi R; Polini B; Ricardi C; Gado F; Mohamed KA; Baron G; Faiella S; Poli G; Rapposelli S; Saccomanni G; Aldini G; Chiellini G; Laprairie RB; Manera C; Ortore G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768458
[TBL] [Abstract][Full Text] [Related]
4. A Photoswitchable Dualsteric Ligand Controlling Receptor Efficacy.
Agnetta L; Kauk M; Canizal MCA; Messerer R; Holzgrabe U; Hoffmann C; Decker M
Angew Chem Int Ed Engl; 2017 Jun; 56(25):7282-7287. PubMed ID: 28510314
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB
Ferrisi R; Gado F; Polini B; Ricardi C; Mohamed KA; Stevenson LA; Ortore G; Rapposelli S; Saccomanni G; Pertwee RG; Laprairie RB; Manera C; Chiellini G
Front Chem; 2022; 10():984069. PubMed ID: 36238097
[TBL] [Abstract][Full Text] [Related]
6. Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB
Rodríguez-Soacha DA; Steinmüller SAM; Işbilir A; Fender J; Deventer MH; Ramírez YA; Tutov A; Sotriffer C; Stove CP; Lorenz K; Lohse MJ; Hislop JN; Decker M
ACS Chem Neurosci; 2022 Aug; 13(16):2410-2435. PubMed ID: 35881914
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol skews biased agonism at cannabinoid CB
Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
[TBL] [Abstract][Full Text] [Related]
8. A Single Point Mutation Blocks the Entrance of Ligands to the Cannabinoid CB
Casajuana-Martin N; Navarro G; Gonzalez A; Llinas Del Torrent C; Gómez-Autet M; Quintana García A; Franco R; Pardo L
J Chem Inf Model; 2022 Nov; 62(22):5771-5779. PubMed ID: 36302505
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
10. Visible-Light Photoswitchable Benzimidazole Azo-Arenes as β-Arrestin2-Biased Selective Cannabinoid 2 Receptor Agonists.
Steinmüller SAM; Fender J; Deventer MH; Tutov A; Lorenz K; Stove CP; Hislop JN; Decker M
Angew Chem Int Ed Engl; 2023 Dec; 62(49):e202306176. PubMed ID: 37269130
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
Reinecke BA; Wang H; Zhang Y
Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
[TBL] [Abstract][Full Text] [Related]
12. Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand Pharmacology.
Braga Emidio N; Small BM; Keller AR; Cheloha RW; Wingler LM
Mol Pharmacol; 2024 Feb; 105(3):260-271. PubMed ID: 38164609
[TBL] [Abstract][Full Text] [Related]
13. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
Pandey P; Roy KK; Doerksen RJ
J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of selective cannabinoid CB
Li X; Chang H; Bouma J; de Paus LV; Mukhopadhyay P; Paloczi J; Mustafa M; van der Horst C; Kumar SS; Wu L; Yu Y; van den Berg RJBHN; Janssen APA; Lichtman A; Liu ZJ; Pacher P; van der Stelt M; Heitman LH; Hua T
Nat Commun; 2023 Mar; 14(1):1447. PubMed ID: 36922494
[TBL] [Abstract][Full Text] [Related]
15. N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R).
Graziano G; Delre P; Carofiglio F; Brea J; Ligresti A; Kostrzewa M; Riganti C; Gioè-Gallo C; Majellaro M; Nicolotti O; Colabufo NA; Abate C; Loza MI; Sotelo E; Mangiatordi GF; Contino M; Stefanachi A; Leonetti F
Eur J Med Chem; 2023 Feb; 248():115109. PubMed ID: 36657299
[TBL] [Abstract][Full Text] [Related]
16. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
Porter RF; Szczesniak AM; Toguri JT; Gebremeskel S; Johnston B; Lehmann C; Fingerle J; Rothenhäusler B; Perret C; Rogers-Evans M; Kimbara A; Nettekoven M; Guba W; Grether U; Ullmer C; Kelly MEM
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540271
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.
Hu SJ; Cheng G; Zhou H; Zhang Q; Zhang QL; Wang Y; Shen Y; Lian CX; Ma XQ; Zhang QY; Qin LP
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163968
[TBL] [Abstract][Full Text] [Related]
18. Rational design of dualsteric GPCR ligands: quests and promise.
Mohr K; Tränkle C; Kostenis E; Barocelli E; De Amici M; Holzgrabe U
Br J Pharmacol; 2010 Mar; 159(5):997-1008. PubMed ID: 20136835
[TBL] [Abstract][Full Text] [Related]
19. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
[TBL] [Abstract][Full Text] [Related]
20. Ligand-Assisted Protein Structure (LAPS): An Experimental Paradigm for Characterizing Cannabinoid-Receptor Ligand-Binding Domains.
Janero DR; Korde A; Makriyannis A
Methods Enzymol; 2017; 593():217-235. PubMed ID: 28750804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
